NCT02974361View on ClinicalTrials.gov

Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 28, 2017

Study Completion Date

May 3, 2017

Conditions
Pharmacokinetics
Interventions
DRUG

Ibuprofen

DRUG

Ibuprofen Lysine

DRUG

Ibuprofen-LDH

Trial Locations (1)

CF48 4DR

Simbec Orion Ltd, Merthyr Tydfil

Sponsors
All Listed Sponsors
lead

Oxford Pharmascience Ltd

INDUSTRY

NCT02974361 - Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen | Biotech Hunter | Biotech Hunter